NCT07532538 A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
| NCT ID | NCT07532538 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
| Condition | Hypopharyngeal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2026-04-30 |
| Primary Completion | 2028-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2026-04-30 with a primary completion date of 2028-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop and validate a clinical prediction model for the risk of head and neck cancerous lesions using deep learning combined with AI algorithms, based on multi-center clinical data.
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years old. Patients with complete clinical data information and laryngoscopic images. Exclusion Criteria: Refusal to sign the informed consent form. Incomplete clinical data. Known diagnosis of other head and neck malignancies (thyroid cancer, malignant parotid tumors, etc.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07532538 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Hypopharyngeal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07532538 currently recruiting?
Yes, NCT07532538 is actively recruiting participants. Contact the research team at songjiu3411@outlook.com for enrollment information.
Where is the NCT07532538 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT07532538 clinical trial?
NCT07532538 is sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.